SH3GL1P1: A Potential Drug Target Or Biomarker (G6458)

Target Name: SH3GL1P1

NCBI ID: G6458

SH3GL1P1

Other Name(s): SH3 domain containing GRB2 like 1, endophilin A2 pseudogene 1 | CNSA-P1 | SH3GLP1

SH3GL1P1: A Potential Drug Target Or Biomarker

SH3GL1P1, also known as SH3 domain containing GRB2 like 1, and endophilin A2 pseudogene 1, is a gene that has been identified as a potential drug target or biomarker. The SH3 domain is a unique protein domain that is found in a variety of proteins, including the GRB2 gene, which is known for its role in cell signaling pathways. The SH3 domain is thought to play a key role in the regulation of cellular processes such as cell adhesion, migration, and signaling pathways.

The GRB2 gene is a member of the tyrosine kinase family, which is a family of transmembrane proteins that play a key role in intracellular signaling. The SH3 domain of GRB2 is a 120 amino acid long region that is located between the N-terminus and the A-terminus of the protein. The SH3 domain is composed of a series of amino acids that are known for their unique structure and function.

One of the key features of the SH3 domain is its ability to interact with other proteins. The SH3 domain contains a variety of different amino acids that are known to form hydrogen bonds with other amino acids in the protein. These interactions can help to regulate the structure and function of the SH3 domain and the surrounding region.

One of the potential functions of the SH3 domain is its role in cell signaling pathways. The SH3 domain has been shown to play a key role in the regulation of cell adhesion and migration. For example, studies have shown that the SH3 domain is involved in the regulation of tight junction formation, which is the process by which cells stick together to form tissues and organs.

In addition to its role in cell signaling pathways, the SH3 domain has also been shown to play a key role in the regulation of protein function. The SH3 domain is thought to help to regulate the stability and localization of other proteins, such as GRB2 itself. This can help to ensure that the SH3 domain is able to interact with other proteins in a specific and efficient manner.

The potential drug target or biomarker properties of the SH3 domain containing GRB2 like 1 are based on its involvement in cell signaling pathways and its ability to interact with other proteins. This suggests that the SH3 domain may be a useful target for the development of new drugs or diagnostic tools for a variety of diseases. Further research is needed to confirm these potential applications and to fully understand the role of the SH3 domain in cellular processes.

Protein Name: SH3 Domain Containing GRB2 Like 1, Endophilin A2 Pseudogene 1

The "SH3GL1P1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SH3GL1P1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets